Trupanion (TRUP) versus Health Insurance Innovations (HIIQ) Head-To-Head Analysis
Trupanion (NASDAQ: TRUP) and Health Insurance Innovations (NASDAQ:HIIQ) are both small-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, institutional ownership, analyst recommendations and profitability.
This table compares Trupanion and Health Insurance Innovations’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Health Insurance Innovations||5.98%||21.32%||13.25%|
Risk & Volatility
Trupanion has a beta of 0.12, indicating that its share price is 88% less volatile than the S&P 500. Comparatively, Health Insurance Innovations has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500.
Institutional & Insider Ownership
62.4% of Trupanion shares are held by institutional investors. Comparatively, 63.7% of Health Insurance Innovations shares are held by institutional investors. 31.2% of Trupanion shares are held by company insiders. Comparatively, 30.0% of Health Insurance Innovations shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Valuation and Earnings
This table compares Trupanion and Health Insurance Innovations’ gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||NetIncome||Earnings Per Share||Price/Earnings Ratio|
|Trupanion||$188.23 million||4.71||-$6.89 million||($0.09)||-327.96|
|Health Insurance Innovations||$184.52 million||2.16||$4.51 million||$1.19||20.25|
Health Insurance Innovations has higher revenue, but lower earnings than Trupanion. Trupanion is trading at a lower price-to-earnings ratio than Health Insurance Innovations, indicating that it is currently the more affordable of the two stocks.
This is a breakdown of recent ratings and target prices for Trupanion and Health Insurance Innovations, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Health Insurance Innovations||0||1||6||0||2.86|
Trupanion currently has a consensus price target of $27.20, suggesting a potential downside of 7.86%. Health Insurance Innovations has a consensus price target of $32.00, suggesting a potential upside of 32.78%. Given Health Insurance Innovations’ stronger consensus rating and higher probable upside, analysts clearly believe Health Insurance Innovations is more favorable than Trupanion.
Health Insurance Innovations beats Trupanion on 10 of the 13 factors compared between the two stocks.
Trupanion Company Profile
Trupanion, Inc. provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers. The other business segment includes other operations that are not directly marketed to consumers. The Company offers a software solution, Trupanion Express, which is designed to facilitate the direct payment of invoices to veterinary practices. Trupanion Express integrates with veterinarians’ practice management software, which allows the Company to access data. The Company’s subsidiaries include American Pet Insurance Company, Trupanion Managers USA, Inc., Trupanion Brokers Ontario, Inc. and Wyndham Insurance Company (SAC), Ltd.
Health Insurance Innovations Company Profile
Health Insurance Innovations, Inc. is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP. The Company’s STM plans are provided up to six months, 11 months, or 364 days of health insurance coverage with a range of deductible and copay levels. Individual major medical (IMM) plans cover prescription drugs, pre-existing conditions and preventive care, while STM plans provide optional coverage for prescription drugs.
Receive News & Stock Ratings for Trupanion Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc. and related stocks with our FREE daily email newsletter.